A phase II trial of gemcitabine in patients with advanced hepatocellular carcinomaCharles S. Fuchs, Keith Stuart, Jeffrey W. Clark et al.|Cancer|2002Cited by 95
A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinomaDavid P. Ryan, Jeffrey W. Clark, Matthew H. Kulke et al.|Cancer|2001Cited by 94
A Phase II trial of gemcitabine for metastatic neuroendocrine tumorsMatthew H. Kulke, Charles S. Fuchs, Haesook Kim et al.|Cancer|2004Cited by 76
A Phase II Trial of Irinotecan in Patients with Previously Untreated Advanced Esophageal and Gastric AdenocarcinomaPeter C. Enzinger, Charles S. Fuchs, Matthew H. Kulke et al.|Digestive Diseases and Sciences|2005Cited by 73
A Phase II Study of Docetaxel in Patients with Metastatic Carcinoid TumorsMatthew H. Kulke, Charles S. Fuchs, Haesook Kim et al.|Cancer Investigation|2004Cited by 61